Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03015350
Other study ID # One lung ventilation
Secondary ID
Status Completed
Phase N/A
First received December 27, 2016
Last updated March 2, 2018
Start date December 2016
Est. completion date December 2017

Study information

Verified date November 2017
Source Cukurova University
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

16 patients with American Society of AnesthesioIogy (ASA) physical status I-III will recruited to this study. Patients will divided to the 2 groups. %1.5 Sevoflurane will apply in Group S and %6 Desflurane will apply in Group D. Each groups will divide 2 subgroups. Two lung ventilation will be performed to Group Sa and Group Da, one lung ventilation will be performed to Group Sb and Group Db. At the time point 40.minutes first blood sample will given from patients. Blood sample will be taken at intervals of 10 minutes from groups of two lung ventilation. In groups of one lung ventilation, blood samples will be taken at the time interval of 10 minutes after one lung ventilation started. All blood samples will be assess in Gas Chromatography.


Description:

Investigator aimed to assess blood level of sevoflurane and desflurane during two lung ventilation and one lung ventilation. The investigators will use Gas Chromatography for define drugs levels. 16 patients with ASA I-III patients who undergo thoracotomy and abdominal surgery will be recruited to this study. Patients will divided in to the 2 groups. %1.5 Sevoflurane will apply in Group S and %6 Desflurane will apply in Group D during anesthesia maintenance. Each groups will divide 2 subgroups which are one lung ventilation groups and two lung ventilation groups. Two lung ventilation will be performed to Group Sa and Group Da, one lung ventilation will be performed to Group Sb and Group Db. Sequential blood samples will be taken from both arterial and central venous canula at the same time point. First blood samples will be taken at 40. minutes of anesthesia. Sequential samples will be taken at interval of 10 minutes during two lung ventilation. In one lung ventilation second blood samples will be taken at the 10. minutes of one lung ventilation. After than at the interval of 10 minutes, collection of blood samples both arterial and central venous will be continue.

All collection will assess with gas chromatography.


Recruitment information / eligibility

Status Completed
Enrollment 16
Est. completion date December 2017
Est. primary completion date December 2017
Accepts healthy volunteers No
Gender All
Age group 25 Years to 65 Years
Eligibility Inclusion Criteria: ASA I-II patients

- Who undergo thoracotomy or abdominal surgery

Exclusion Criteria:

- ASA IV and up patients

- Patients who taken inotropic agent

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Sevoflurane
Measurement of blood desflurane level during one lung ventilation
Desflurane
Measurement of blood desflurane level during one lung ventilation

Locations

Country Name City State
Turkey Ebru Biricik Adana In The USA Or Canada, Please Select...

Sponsors (1)

Lead Sponsor Collaborator
Cukurova University

Country where clinical trial is conducted

Turkey, 

Outcome

Type Measure Description Time frame Safety issue
Primary Measurement of blood levels of Sevoflurane and Desflurane Data collections will be ensured from arterial and venous blood sample and than samples will be assessed with gas chromatography and blood sevoflurane and desflurane level will be measured. Blood samples will take every 10 minutes. Only blood levels of sevoflurane and desflurane will be assessed. from 40th minute to the end of the operation
Secondary determine of ventilation-perfusion mismatch with p(A-a)O2 During one lung ventilation, p(a-A)O2 will be assessed with arterial blood analyses from 40th minute to the end of the one lung ventilation
See also
  Status Clinical Trial Phase
Recruiting NCT05867472 - Advancing Brain Outcomes in Pediatric Critically Ill Patients Sedated With Volatile AnEsthestic Agents Phase 3
Completed NCT01285271 - A Pre- and Post- Coronary Artery Bypass Graft Implantation Disposed Application of Xenon Phase 3
Completed NCT03553446 - 50% Effective Concentration of Sevoflurane for Immobility N/A
Recruiting NCT05511584 - Oxygen Consumption and Sevoflurane Uptake Based on Physiological Dead Space Estimation N/A
Completed NCT03795259 - Effect of Rocuronium and Sugammadex Under Sevoflurane and Desflurane Anesthesia in Children N/A